I am in favor of market forces and transparent pricing instead of 3rd parties hiding of costs, but as you allude to here but not strongly enough - it appears that FDA foot dragging and cronyism may have helped Mylan keep its "monopoly" and thus monopoly like pricing for now....Price gauging on a life-saving product that has few, if any, cheaper alternatives, or no alternatives that work as well under the circumstances for which it is designed, is...what's the technical term? Icky.
And market forces don't work so well if Apple or Gillette pays off Congress to create a market that favors iPhones or battery-operated 20-blade cartridges, particularly where the CEO has a family connection. Again, icky.
Interesting intersection of politics going on with this medication (not here on B&B but in congress and presidential races). The Mylan CEO is not a sympathetic person but I think she makes some interesting points today on CNBC that need to be considered in the holistic approach to healthcare.